fbpx
Image Alt

Investment Thesis

  /  Investment Thesis

With gold commodity prices hovering near all-time highs, I have noticed a significant disconnect between strong market fundamentals and the performance of many high-quality mining names. Despite the surge in gold, a number of these miners have not yet seen this reflected in their share prices, creating an attractive and skewed risk-reward opportunity for investors.

They always say to follow the smart money and Billionaire Mining Legend Eric Sprott recently increased his stake in Golden Spike Resources Corp (CSE: GLDS) (OTCQB: GSPRF) to over 10%, positioning him as an insider and major influencer in Golden Spike’s future. Eric isn’t the only industry heavyweight that has recently become involved

Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) is a preclinical stage pharmaceutical company with a groundbreaking focus on telomere regeneration and age-related inflammatory diseases. Its lead drug candidate, Telomir-1, presents a novel approach to extending telomeres, potentially reversing aging processes and addressing age related conditions such as osteoarthritis.